Addition of cyclophosphamide and higher doses of dexamethasone do not improve outcomes of patients with AL amyloidosis treated with bortezomib.
Kastritis E, Gavriatopoulou M, Roussou M, Fotiou D, Ziogas DC, Migkou M, Eleutherakis-Papaiakovou E, Panagiotidis I, Kanellias N, Psimenou E, Papadopoulou E, Pamboucas C, Manios E, Gakiopoulou H, Ntalianis A, Tasidou A, Giannouli S, Terpos E, Dimopoulos MA.
Kastritis E, et al. Among authors: panagiotidis i.
Blood Cancer J. 2017 Jun 16;7(6):e570. doi: 10.1038/bcj.2017.47.
Blood Cancer J. 2017.
PMID: 28622303
Free PMC article.